ITR/AP: Collaborative Research: Cancer Treatment Plan Optimization
ITR/AP: Collaborative Research: Cancer Treatment Plan Optimization
批准号:
0113045
负责人:
David Shepard
金额:
$16.23万
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-09-15 至 2005-08-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This project will use new techniques from computational optimization to design radiation therapy planning for cancer treatment. Radiation therapy applies ionizing radiation to cancerous tissue, damaging the DNA and interfering with the ability of the cancerous cells to grow and divide. This also damages healthy cells, but they are more able to repair the damage and return to normal function. The therapy planning problem is to specify the shapes of the applied radiation beams, times of exposure, etc., to deliver a specified dose to the tumor but not an excessive dose to the surrounding healthy tissue. New medical devices allow much control over the characteristics of the radiation, thus allowing much scope for the therapy planning. However, the full potential of these devices to deliver optimal treatment plans has yet to be realized due to the complexity of the treatment design process. By using advanced modeling techniques, state-of-the-art optimization algorithms, and implementations on parallel computing platforms this project will provide radiation oncologists with important new computational tools for treatment planning. These tools will be flexible enough to adapt to the varying priorities of different planners and different patients and robust enough to give good solutions to the most difficult planning problems. The project involves collaboration between three researchers whose collective expertise encompasses radiation oncology modeling, optimization algorithms, and parallel implementations. It builds on previous collaborations of these researchers on treatment planning and on NSF-funded work on algorithms for solving large optimization problems.The institutions involved in the project are the University of Wisconsin, the University of Maryland School of Medicine, and the University of Chicago.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Collaborative Research: ITR-(ASE)-(dmc): Overcoming Fractionation Errors in Cancer Treatement Planning
-
批准号:0749671
-
项目类别:Standard Grant
-
资助金额:$0.0万
-
财政年份:2006
-
负责人:David Shepard
-
依托单位:
Collaborative Research: ITR-(ASE)-(dmc): Overcoming Fractionation Errors in Cancer Treatement Planning
-
批准号:0453423
-
项目类别:Standard Grant
-
资助金额:$15.0万
-
财政年份:2004
-
负责人:David Shepard
-
依托单位:
国内基金
海外基金
登录
查看更多内容
HTG-AP 患者健康行为依从性预测模型及移动健康管理模式的构建与实证研究
-
批准号:2026JJ81374
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:杨宏
-
依托单位:
AP4M1通过USP15去泛素化作用抑制铁死亡促进肝癌进展的机制研究
-
批准号:2026JJ50091
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:周扬莹
-
依托单位:
Al@AP微单元复合体系燃烧机理及模型预示研究
-
批准号:JCZRLH202601568
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
雌激素通过AP-1靶向调控TASK-1双孔钾通道参与阿尔茨海默病神经保护的机制研究
-
批准号:JCZRLH202601678
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于抑制AP-1信号增强胆管癌光动力治疗并逆转免疫抑制微环境的分子机制与靶向干预研究
-
批准号:JCZRQN202500115
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
FTO/AP-2α-m6A/LITAF反馈环路调控子痫前期滋养细胞迁移和侵袭的作用和机制研究
-
批准号:2025JJ50721
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:李瑞珍
-
依托单位:
脑胶质瘤抑瘤基因LRRC4促进含AP2A1的高尔基体网格囊泡释放调控线粒体嵴结构与氧化磷酸化影响胶质母细胞瘤生长和侵袭的机制研究
-
批准号:2025JJ60498
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:李洋
-
依托单位:
Ap-Exo III 联合模式识别构建降尿酸药
物筛选新方法的研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:刘利红
-
依托单位:
新融合基因AP1B1-EWSR1促进骨肉瘤发生发展的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:吕杨帆
-
依托单位:
AP-1激活miR-22/miR-210反馈调控文昌鱼JNK通路先天免疫响应的机制研究
-
批准号:QN25C040003
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:曹云鹏
-
依托单位: